Atb Cap Markets Forecasts Organigram FY2027 Earnings

Organigram Holdings Inc. (NASDAQ:OGI - Free Report) - Research analysts at Atb Cap Markets issued their FY2027 EPS estimates for shares of Organigram in a research report issued on Tuesday, February 11th. Atb Cap Markets analyst F. Gomes expects that the company will earn $0.06 per share for the year. The consensus estimate for Organigram's current full-year earnings is ($0.09) per share. Atb Cap Markets also issued estimates for Organigram's FY2028 earnings at $0.14 EPS.

Organigram (NASDAQ:OGI - Get Free Report) last released its quarterly earnings data on Tuesday, February 11th. The company reported ($0.05) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.02). Organigram had a negative net margin of 28.58% and a negative return on equity of 11.68%.

Organigram Price Performance

NASDAQ OGI traded down $0.08 during midday trading on Thursday, hitting $1.27. 2,053,741 shares of the company traded hands, compared to its average volume of 591,882. Organigram has a 52 week low of $1.27 and a 52 week high of $2.91. The company's 50-day simple moving average is $1.55 and its 200-day simple moving average is $1.66. The company has a market cap of $160.22 million, a PE ratio of -3.34 and a beta of 1.00.

Institutional Trading of Organigram

Institutional investors have recently modified their holdings of the company. Two Sigma Securities LLC acquired a new stake in Organigram in the fourth quarter valued at approximately $26,000. Toronto Dominion Bank boosted its position in shares of Organigram by 803.7% in the 3rd quarter. Toronto Dominion Bank now owns 16,727 shares of the company's stock worth $30,000 after purchasing an additional 14,876 shares in the last quarter. Oxford Asset Management LLP acquired a new stake in Organigram in the fourth quarter worth about $50,000. Clear Harbor Asset Management LLC boosted its holdings in Organigram by 37.4% in the fourth quarter. Clear Harbor Asset Management LLC now owns 45,000 shares of the company's stock worth $72,000 after acquiring an additional 12,250 shares in the last quarter. Finally, Cubist Systematic Strategies LLC grew its stake in shares of Organigram by 210.7% during the fourth quarter. Cubist Systematic Strategies LLC now owns 45,095 shares of the company's stock worth $73,000 after acquiring an additional 30,583 shares during the last quarter. 34.63% of the stock is currently owned by institutional investors.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.